Sangam Health Care Products Ltd appointed T. Abhilash as its Company Secretary and Compliance Officer with effect from October 12, 2026. The appointment was approved by the Board of Directors during a meeting held at the company's registered office in Hyderabad.

Abhilash is an associate member of the Institute of Company Secretaries of India (ICSI) with membership number A36423. He brings experience in corporate legal and secretarial services to the role. The Board designated him to handle all functions prescribed under Section 203 of the Companies Act, 2013.

Regulatory compliance responsibilities

In addition to his secretarial duties, Abhilash will serve as the Compliance Officer as required under Regulation 6 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This dual role ensures alignment with statutory governance norms for listed entities.

The disclosure was made to BSE Limited under Regulation 30 of the Listing Regulations, read along with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The board meeting commenced at 10:40 am and concluded at 11:00 am IST on the same day.

Appointment details

The company confirmed that there are no relationships between the new appointee and existing directors, ensuring independence in the compliance function.

Sangam Health Care Products Limited adopted its audited financial statements for FY26 and reappointed Bhagat Reddy Dundumulla as Managing Director during its 32nd Annual General Meeting held on September 30, 2026. The meeting, conducted at the company’s facility in Medchal District, Telangana, saw all proposed resolutions passed with 100% votes in favour.

The Board of Directors had appointed M/s Chakravarthy & Associates as the scrutinizer to supervise the voting process. Notably, the company did not enable remote online e-voting options for this AGM, relying exclusively on physical ballot papers cast by shareholders present at the venue.

Key resolutions passed

Shareholders approved four key items of business, including the adoption of the Balance Sheet, Statement of Profit & Loss, and Cash Flow Statement for the year ended March 31, 2026. The following directorial changes were also ratified:

• Reappointment of Non-Executive Director: Mr. Sai Balaji Krishna Teja Addepalli was reappointed in place of himself, having retired by rotation and offered himself for reappointment.
• Continuation of Directorship: Mrs. Padma Ghanakota was approved for continuation as a Non-Executive and Non-Independent Director.
• Reappointment of Managing Director: A special resolution was passed to reappoint Mr. Bhagat Reddy Dundumulla as Managing Director.

Voting details

The voting results indicate a high level of consensus among attendees, with no votes cast against any resolution. The promoter group, holding 10,421,040 shares, voted in favour of all items. Public institutions and non-institutional shareholders also supported all resolutions unanimously.

Governance structure

The total number of shares outstanding stood at 14,860,700, with 8,116,790 votes polled, representing approximately 54.62% of the outstanding share capital. The promoter and promoter group accounted for the majority of the votes polled, casting 75,41,140 votes. Public institutions contributed 2,00,000 votes, while public non-institutions cast 3,75,650 votes.

The scrutinizer’s report confirmed that all physical ballot papers were serially numbered, sorted, and reconciled with records maintained by the Registrar and Share Transfer Agent. No invalid votes were recorded across any of the four resolutions.